A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2011
08/25/2011	WO2011080269A3 Pharmaceutical preparations comprising a cos releasing compound
08/25/2011	WO2011025344A3 Attenuated salmonella mutants wherein adhesin of bovine pathogenic escherichia coli is transformed, and vaccine composition for preventing and treating bovine colibacillosis and salmonellosis comprising same
08/25/2011	WO2011011522A3 Potent small molecule inhibitors of autophagy, and methods of use thereof
08/25/2011	US20110209228 Method of treatment using antimicrobial composition
08/25/2011	US20110207823 12-hour sustained-release metoclopramide
08/25/2011	US20110207799 Compositions for Targeted Delivery of siRNA
08/25/2011	US20110207797 Enhanced antisense oligonucleotides
08/25/2011	US20110207780 Therapeutic Salt Compositions and Methods
08/25/2011	US20110207779 Process for the preparation of esomeprazole magnesium
08/25/2011	US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors
08/25/2011	US20110207764 Cyclopolysaccharide compositions
08/25/2011	US20110207763 8-carboxamido-2,6-methano-3-benzazocines
08/25/2011	US20110207756 Antitumor agent for thyroid cancer
08/25/2011	US20110207746 New compounds i
08/25/2011	US20110207734 Azine Derivatives and Methods of Use Thereof
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207711 Therapeutic Compounds
08/25/2011	US20110207704 Novel Oxadiazole Compounds
08/25/2011	US20110207700 Tricyclic compound and use thereof
08/25/2011	US20110207694 Mammalian hypothalamic nutrient modulation of glucose metabolism
08/25/2011	US20110207682 Pharmaceutical composition useful for the treatment of peptic ulcer diseases
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207677 Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Chronic or Non-Chronic Inflammatory Digestive Diseases
08/25/2011	US20110207663 Fibroblast growth factor (fgf) analogs and uses thereof
08/25/2011	US20110207660 Pharmaceutical formulations of an hcv protease inhibitor in a solid molecular dispersion
08/25/2011	US20110207224 In vivo production of small interfering rnas that mediate gene silencing
08/25/2011	US20110206779 Gastric ulcer therapeutic agent
08/25/2011	US20110206763 Rapid-release encapsulation composition
08/25/2011	US20110206741 DHA Triglyceride Emulsions
08/25/2011	US20110206721 Fermented soy nutritional supplements including mushroom components
08/25/2011	US20110206684 Method of producing nutritional products from human milk tissue and compositions thereof
08/25/2011	US20110206669 Mcp1 fusions
08/25/2011	US20110206654 Methods of Modulating Gastrointestinal Tract Flora Levels with Alkaline Phosphatase
08/25/2011	US20110206650 Probiotic Formulations
08/25/2011	US20110206641 Stress tolerant bifidobacteria
08/25/2011	US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011	DE102010008982A1 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie A silicon-containing biologically degradable material for anti-inflammatory therapy
08/25/2011	DE102010008981A1 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie A silicon-containing biologically degradable material for pro-angiogenic therapy
08/25/2011	CA2789665A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
08/24/2011	EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011	EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
08/24/2011	EP2360251A2 In vivo production of small interfering RNAs that mediate gene silencing
08/24/2011	EP2360185A2 Administration of agents for the treatment of inflammation
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
08/24/2011	EP2359869A2 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same and uses therefor
08/24/2011	EP2359855A2 Methods of administering anti-TNFalpha antibodies
08/24/2011	EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines
08/24/2011	EP2358702A2 Piperidine compounds, pharmaceutical composition comprising the same and its use
08/24/2011	EP2358680A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
08/24/2011	EP2358378A2 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
08/24/2011	EP2110133B1 Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
08/24/2011	EP1571155B1 Peptides and medicinal compositions containing the same
08/24/2011	EP1506774B1 Smooth muscle peristole inhibitor
08/24/2011	EP1505990B1 Methods of treating hepatitis
08/24/2011	EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
08/24/2011	EP1485353B1 New inhibitors of histone deacetylase
08/24/2011	EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
08/24/2011	EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases
08/24/2011	EP1259544B1 Heterologous polypeptide of the tnf family
08/24/2011	CN1976923B Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation
08/24/2011	CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides
08/24/2011	CN102164940A TGR5 modulators and methods of use thereof
08/24/2011	CN102164920A Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor
08/24/2011	CN102164917A Compounds which selectively modulate the CB2 receptor
08/24/2011	CN102164916A Compounds which selectively modulate the CB2 receptor
08/24/2011	CN102164902A 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
08/24/2011	CN102164599A Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
08/24/2011	CN102164596A Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
08/24/2011	CN102164590A Therapeutic agent for tympanites in ruminant animal
08/24/2011	CN102161963A Grass root wine and preparation method thereof
08/24/2011	CN102161710A Method for preparing tremellan with low molecular weight and novel medicinal application thereof
08/24/2011	CN102160886A Compound buccal tablet containing sodium azulene sulfonate and application
08/24/2011	CN102160875A Blood-nourishing skin-moisturizing health product
08/24/2011	CN101912592B Traditional Chinese medicine preparation for treating irritable bowel syndrome
08/24/2011	CN101869660B Capsules for treating chronic fatigue syndrome and climacteric syndrome
08/24/2011	CN101843879B Chinese medicament for treating liver cirrhosis
08/24/2011	CN101822726B Medicine or healthcare food with liver protection function
08/24/2011	CN101773602B Epimedium kidney-tonifying wine
08/24/2011	CN101745069B Preparation process of Chinese patent medical granule for treating ulcerative colitis
08/24/2011	CN101744915B Medicament for treating maternal-fetal ABO incompatibility
08/24/2011	CN101732651B Chinese medicament for treating gastropathy
08/24/2011	CN101721382B Lansoprazole submicron emulsion solid preparation and novel application thereof
08/24/2011	CN101711808B Soft capsule used for clearing away heat and toxic materials and preparation method thereof
08/24/2011	CN101708229B Oral tablet and preparation method thereof
08/24/2011	CN101703611B Quality detection method of Chinese angelica oral liquid for benefiting blood
08/24/2011	CN101690786B Traditional Chinese medicine for treating chronic gastritis
08/24/2011	CN101658618B Anti-alcoholism liver protecting compound preparation and applications thereof
08/24/2011	CN101607062B Chinese traditional medicine composition for treating recurrent oral ulcer
08/24/2011	CN101472580B Therapeutic or prophylactic agent for allergic dermatitis
08/24/2011	CN101468171B Medicament for weight-reducing of fat people and weight-gaining of thin people
08/24/2011	CN101366858B Preparation method of medicament for clearing heat, discharging fire, dispelling wind and relieving pain
08/24/2011	CN101361535B Compound pollen cream and preparation method thereof
08/24/2011	CN101327246B Radix astragali medicinal materials, intermediate body and method for testing fingerprint of formulation thereof as well as standard fingerprint
08/24/2011	CN101312967B Carbamate compounds as 5-ht4 receptor agonists
08/24/2011	CN101293830B 1-oxygen-[3-aryl substituted-alkene propionyl]quinic acid compounds and uses
08/24/2011	CN101264169B Alcohol-clearing liver nourishing capsule and manufacturing technique
08/24/2011	CN101249143B Preparation for increasing medicinal value of Parasitism in Cistanche decoction pieces
08/24/2011	CN101220371B Recombined bifidobacteria hRV-VP4 expression vector and oral vaccine thereof
08/24/2011	CN101204447B Anti-hepatitis-jaundice soft capsule and preparation method thereof

1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 1258